Please login to the form below

Not currently logged in
Email:
Password:

bipolar disorder

This page shows the latest bipolar disorder news and features for those working in and with pharma, biotech and healthcare.

Sage raises $575m ahead of FDA review date for Zulresso

Sage raises $575m ahead of FDA review date for Zulresso

It also has an FDA breakthrough designation for this indication. The follow-up is also being developed in a phase 3 programme as a short oral course for major depressive disorder, ... It is also in earlier-stage studies for MDD plus insomnia as a

Latest news

More from news
Approximately 7 fully matching, plus 81 partially matching documents found.

Latest Intelligence

  • Drug pricing in Ireland Drug pricing in Ireland

    As such, patients with coronary syndromes, multiple sclerosis, bipolar disorder and Hepatitis C were being denied access to effective treatments, while treatments for other diseases were also subject to restrictions.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics